
Our pediatric nurses are critical to providing your child with innovative and compassionate care.
Our neuroblastoma experts — including five board-certified oncologists and five nurse practitioners singularly focused on treating neuroblastoma — work as a team to give your child the best possible outcome and quality of care possible. Our experts are among the best in the world, and we’ll do everything in our power to help your child beat this disease.
As our patient, your child will see the same team of healthcare professionals during his or her entire neuroblastoma treatment process. This integrated care is personalized to your child’s needs.
You’ll also have a lot of interaction with our pediatric nurses. Each of them brings great knowledge, experience, and expertise to your child’s care, and we hope you feel comfortable asking them questions and seeking their guidance. They’re experts in neuroblastoma and can help in a variety of ways.
If your child is receiving antibody therapy for neuroblastoma you’ll likely have a lot of contact with our two full-time research nurses dedicated to this form of treatment.
Find more information about our experts below. To make an appointment, please call the Department of Pediatrics at 833-MSK-KIDS.

Nai-Kong V. Cheung
Head, Neuroblastoma Program; Enid A. Haupt Chair in Pediatric Oncology

Ellen M. Basu

Julia Glade Bender
Vice Chair for Clinical Research

Kim Kramer

Brian H. Kushner

Shakeel Modak
Acting Chief of Neuroblastoma Service

Stephen S. Roberts
Director, Pediatric Hematology-Oncology Fellowship Program

J. Ted Gerstle
Chief, Pediatric Surgical Service

Todd E. Heaton

Michael P. La Quaglia
Joseph H. Burchenal Chair in Pediatrics

Edward Shlasko

Katherine Alessi

Linda D'Andrea

Debbie Diotallevi

Christina Durney
Nurse Practitioner

Rachel Glincher
Nurse Practitioner

Latisha Jones

Christine Kasper

Yi-Chih Lin

Mariel Marrano
Nurse Practitioner

Lauren Martino
Nurse Practitioner

Ursula McPeak Tomlinson

Raymond Ng

Elaine Pottenger

Josephine See
Nurse Practitioner

Danielle Novetsky Friedman

Charles A. Sklar
Director, Long-Term Follow-Up Program